RPTX
Repare Therapeutics Inc
NASDAQ: RPTX · HEALTHCARE · BIOTECHNOLOGY
$2.65
+0.00% today
Updated 2026-01-28
Market cap
$114.24M
P/E ratio
—
P/S ratio
9.62x
EPS (TTM)
$-1.70
Dividend yield
—
52W range
$1 – $3
Volume
1.4M
Repare Therapeutics Inc (RPTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-0.04%
ROE
-0.50%
ROA
-0.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $0.00 | $-7.80M | — | — | — |
| 2018 | $0.00 | $-14.28M | — | — | — |
| 2019 | $0.00 | $-27.22M | — | — | — |
| 2020 | $135000.00 | $-53.42M | -28,622.22% | -40,223.70% | -39,568.15% |
| 2021 | $7.60M | $-106.91M | -1,055.97% | -1,429.74% | -1,406.68% |
| 2022 | $131.83M | $-29.05M | 11.46% | -15.02% | -22.03% |
| 2023 | $51.13M | $-93.80M | 74.11% | -227.30% | -183.44% |
| 2024 | $53.48M | $-84.69M | 74.98% | -174.88% | -158.37% |